1. Home
  2. CYTK vs ST Comparison

CYTK vs ST Comparison

Compare CYTK & ST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ST
  • Stock Information
  • Founded
  • CYTK 1997
  • ST 1916
  • Country
  • CYTK United States
  • ST United States
  • Employees
  • CYTK N/A
  • ST N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ST Industrial Machinery/Components
  • Sector
  • CYTK Health Care
  • ST Industrials
  • Exchange
  • CYTK Nasdaq
  • ST Nasdaq
  • Market Cap
  • CYTK 5.0B
  • ST 5.3B
  • IPO Year
  • CYTK 2004
  • ST 2010
  • Fundamental
  • Price
  • CYTK $50.26
  • ST $29.49
  • Analyst Decision
  • CYTK Strong Buy
  • ST Buy
  • Analyst Count
  • CYTK 17
  • ST 13
  • Target Price
  • CYTK $82.00
  • ST $39.08
  • AVG Volume (30 Days)
  • CYTK 1.9M
  • ST 2.0M
  • Earning Date
  • CYTK 02-27-2025
  • ST 02-11-2025
  • Dividend Yield
  • CYTK N/A
  • ST 1.63%
  • EPS Growth
  • CYTK N/A
  • ST N/A
  • EPS
  • CYTK N/A
  • ST 0.85
  • Revenue
  • CYTK $3,219,000.00
  • ST $3,932,764,000.00
  • Revenue This Year
  • CYTK N/A
  • ST N/A
  • Revenue Next Year
  • CYTK $754.18
  • ST $5.38
  • P/E Ratio
  • CYTK N/A
  • ST $34.62
  • Revenue Growth
  • CYTK N/A
  • ST N/A
  • 52 Week Low
  • CYTK $40.53
  • ST $24.91
  • 52 Week High
  • CYTK $81.36
  • ST $43.14
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 58.40
  • ST 61.75
  • Support Level
  • CYTK $45.05
  • ST $25.42
  • Resistance Level
  • CYTK $48.30
  • ST $30.28
  • Average True Range (ATR)
  • CYTK 2.80
  • ST 0.92
  • MACD
  • CYTK 0.61
  • ST 0.46
  • Stochastic Oscillator
  • CYTK 86.80
  • ST 85.29

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ST Sensata Technologies Holding plc

Sensata Technologies is a global supplier of sensors for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.

Share on Social Networks: